Bank of America’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$344M Buy
1,752,902
+129,964
+8% +$25.3M 0.03% 518
2025
Q4
$282M Sell
1,622,938
-12,137
-0.7% -$2.21M 0.02% 594
2025
Q3
$312M Buy
1,635,075
+35,473
+2% +$6.3M 0.02% 610
2025
Q2
$287M Buy
1,599,602
+426,399
+36% +$74.1M 0.02% 629
2025
Q1
$199M Buy
1,173,203
+456,586
+64% +$75M 0.02% 725
2024
Q4
$108M Sell
716,617
-91,934
-11% -$14.3M 0.01% 989
2024
Q3
$126M Sell
808,551
-54,165
-6% -$8.09M 0.01% 946
2024
Q2
$118M Sell
862,716
-166,038
-16% -$22.7M 0.01% 928
2024
Q1
$137M Buy
1,028,754
+5,370
+0.5% +$697K 0.01% 851
2023
Q4
$141M Sell
1,023,384
-87,480
-8% -$11.5M 0.01% 772
2023
Q3
$135M Sell
1,110,864
-37,280
-3% -$4.97M 0.01% 750
2023
Q2
$161M Sell
1,148,144
-252,923
-18% -$34.9M 0.02% 682
2023
Q1
$198M Sell
1,401,067
-79,170
-5% -$11.3M 0.02% 636
2022
Q4
$232M Sell
1,480,237
-1,454,653
-50% -$209M 0.03% 542
2022
Q3
$360M Sell
2,934,890
-87,975
-3% -$11.6M 0.04% 390
2022
Q2
$402M Sell
3,022,865
-605,407
-17% -$82.5M 0.05% 370
2022
Q1
$497M Buy
3,628,272
+398,924
+12% +$55.6M 0.05% 340
2021
Q4
$559M Buy
3,229,348
+64,550
+2% +$9.82M 0.05% 319
2021
Q3
$460M Sell
3,164,798
-315,675
-9% -$46.2M 0.05% 356
2021
Q2
$459M Buy
3,480,473
+141,643
+4% +$18.5M 0.05% 363
2021
Q1
$429M Buy
3,338,830
+336,312
+11% +$41.4M 0.05% 354
2020
Q4
$358M Sell
3,002,518
-303,476
-9% -$37M 0.05% 351
2020
Q3
$379M Buy
3,305,994
+2,623,528
+384% +$310M 0.05% 325
2020
Q2
$77.8M Buy
682,466
+12,020
+2% +$1.27M 0.01% 805
2020
Q1
$53.8M Sell
670,446
-154,527
-19% -$16M 0.01% 919
2019
Q4
$88.1M Sell
824,973
-224,722
-21% -$23.4M 0.01% 836
2019
Q3
$112M Sell
1,049,695
-1,165,269
-53% -$120M 0.02% 683
2019
Q2
$226M Buy
2,214,964
+230,620
+12% +$22.2M 0.03% 445
2019
Q1
$178M Buy
1,984,344
+575,318
+41% +$49.9M 0.03% 514
2018
Q4
$117M Sell
1,409,026
-69,930
-5% -$6.56M 0.02% 611
2018
Q3
$160M Sell
1,478,956
-38,717
-3% -$4.25M 0.02% 551
2018
Q2
$167M Sell
1,517,673
-132,047
-8% -$13.8M 0.03% 504
2018
Q1
$165M Sell
1,649,720
-35,300
-2% -$3.62M 0.03% 510
2017
Q4
$166M Sell
1,685,020
-485,965
-22% -$46.1M 0.03% 513
2017
Q3
$203M Buy
2,170,985
+162,345
+8% +$17.2M 0.03% 471
2017
Q2
$223M Buy
2,008,640
+121,337
+6% +$12.8M 0.04% 396
2017
Q1
$185M Buy
1,887,303
+11,399
+0.6% +$1.09M 0.04% 433
2016
Q4
$172M Buy
1,875,904
+21,913
+1% +$1.89M 0.04% 446
2016
Q3
$157M Sell
1,853,991
-54,187
-3% -$4.55M 0.03% 472
2016
Q2
$155M Sell
1,908,178
-262,221
-12% -$20M 0.04% 463
2016
Q1
$155M Buy
2,170,399
+117,720
+6% +$7.89M 0.04% 447
2015
Q4
$146M Sell
2,052,679
-70,902
-3% -$4.77M 0.03% 502
2015
Q3
$131M Buy
2,123,581
+1,327,896
+167% +$92.8M 0.03% 544
2015
Q2
$57.7M Sell
795,685
-162,166
-17% -$12M 0.02% 784
2015
Q1
$73.6M Sell
957,851
-542,181
-36% -$38.8M 0.02% 640
2014
Q4
$101M Sell
1,500,032
-4,485,976
-75% -$283M 0.04% 544
2014
Q3
$363M Sell
5,986,008
-65,307
-1% -$4.02M 0.12% 190
2014
Q2
$355M Buy
6,051,315
+5,826,649
+2,593% +$341M 0.11% 187
2014
Q1
$13M Sell
224,666
-3,209,852
-93% -$172M ﹤0.01% 1579
2013
Q4
$184M Buy
3,434,518
+3,086,532
+887% +$183M 0.07% 297
2013
Q3
$21.5M Buy
347,986
+73,668
+27% +$4.41M 0.01% 1229
2013
Q2
$16.6M Buy
+274,318
New +$16.3M 0.01% 1345

Other funds holding DGX

Bank of America's DGX Position: Q1 2026 in Review

Bank of America increased its Quest Diagnostics (DGX) stake by 8% in Q1 2026, buying an estimated $25.3M and bringing the position to 1,752,902 shares worth $344M. The position accounts for 0.03% of the portfolio, ranked #518.

Bank of America first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $559M in Q4 2021. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Bank of America held 1,752,902 shares of Quest Diagnostics worth $344M as of Q1 2026.
  • Bank of America bought 129,964 Quest Diagnostics shares in Q1 2026, an estimated $25.3M.
  • Quest Diagnostics made up 0.03% of Bank of America's portfolio in Q1 2026, its #518 holding.
  • Bank of America first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Quest Diagnostics position peaked at $559M in Q4 2021.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.